France – Produits pharmaceutiques – MARCHE SPECIFIQUE 2026 MEDICAMENTS INTERMEDIAIRE 1
AI summary
This tender concerns the supply of pharmaceutical medicines for member establishments of the GCS Pharma Hauts de France grouping. Suppliers must meet technical specifications and requirements defined in the consultation letter.
Pharmaceutical manufacturers or authorized distributors with capability to supply hospital-grade medicines to multiple facilities across the Hauts-de-France region.
Suppliers must provide medicines that meet defined technical specifications and comply with pharmaceutical regulations applicable to hospital supply chains in France.
Frequently asked questions
What is this tender about?
This tender concerns the supply of pharmaceutical medicines for member establishments of the GCS Pharma Hauts de France grouping. Suppliers must meet technical specifications and requirements defined in the consultation letter.
What are the requirements for suppliers?
Suppliers must provide medicines that meet defined technical specifications and comply with pharmaceutical regulations applicable to hospital supply chains in France.
What type of company should bid?
Pharmaceutical manufacturers or authorized distributors with capability to supply hospital-grade medicines to multiple facilities across the Hauts-de-France region.
Who is the buyer?
The buyer is Centre Hospitalier de Valenciennes.
La présente consultation a pour objet la fourniture de médicaments pour le compte des établissements adhérents au GCS Pharma Hauts de France. Les caractéristiques techniques des fournitures devront répondre aux prescriptions définies par la présente lettre de consultation.
Documents not listed
ILOPROST INJECTABLE
LACOSAMIDE FORME INJECTABLE
DALBAVANCINE CHLORHYDRATE
- PricePRIX ET TECHNIQUE
Computing match…
AI document analysis
We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.
Loading…